Randomized phase of XanaMIA pivotal trial of oral Xanamem 10 mg remains on track for topline final results in November ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes ...

A multi-center clinical trial is now enrolling patients to test whether surgically implanted electrodes delivering continuous ...

There are currently no FDA-approved drugs for treating the disorder ...

GlyphAgo achieved therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or ...

Researchers have found in PRONTO randomized study that addition of procalcitonin to a sepsis diagnostic algorithm in the emergency department did not delay IV antibiotic administration, but ...

Dietary fiber supplementation shows potential in managing blood sugar levels and preventing preterm births in pregnancies at ...

The breaks at the Huntington’s Disease Therapeutics Conference are a great way to thaw out in CA’s February sunshine, take in the beautiful mountain views of Palm Springs, and network with ~450 ...

A science-backed deep dive into how creatine enhances muscle growth, supports brain health, and improves mood, memory, and ...

PureTech Health plc (NASDAQ: PRTC) jumped Thursday. The company, calling itself a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, ...

Helping patients get groceries and make meals while staying on a DASH-approved diet not only helped, but people liked it, too ...

A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...